Anti-mouse PD-1 (CD279)-InVivo

製品コード：A2122         Batch: A212253

印刷

Anti-mouse PD-1 (CD279)-InVivo (Clone:RMP1-14)reacts with mouse PD-1 (programmed death-1) also known as CD279. PD-1 is a 50-55 kDa cell surface receptor encoded by the Pdcd1 gene that belongs to the CD28 family of the Ig superfamily.

製品説明

Formulation PBS Buffer, PH 7.4
Clone RMP1-14
Isotype Rat IgG2a, κ
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C and avoid freeze-thaw cycle
Shipping Shipped under low temperature conditions
Sterility 0.2 μM filtered
Purity 99%
Protein concentration 5.50 mg/ml
Endotoxin Level ＜1EU/mg

カスタマーフィードバック

A2122-Anti-mouse PD-1 (CD279)-InVivo.gif

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

Differential expression pattern of CC chemokine receptor 7 guides precision treatment of hepatocellular carcinoma [ Signal Transduct Target Ther, 2025, 10(1):229] PubMed: 40685403
Ultra-high dose rate radiotherapy overcomes radioresistance in head and neck squamous cell carcinoma [ Signal Transduct Target Ther, 2025, 10(1):82] PubMed: 40032871
Massively parallel interrogation of human functional variants modulating cancer immunosurveillance [ Signal Transduct Target Ther, 2025, 10(1):88] PubMed: 40102418
Nanosized Shikonin Disrupts Tumor-Cell Mismatch Repair and Synergizes with Manganese to Sensitize Squamous Carcinoma to Immunotherapy [ ACS Nano, 2025, 19(14):13889-13905] PubMed: 40190094
The mechanism of YAP/TAZ transactivation and dual targeting for cancer therapy [ Nat Commun, 2025, 16(1):3855] PubMed: 40274828
A Multifunctional Fe-EGCG@RSL3 Nanomedicine Synergizes Ferroptosis Induction and Tumor Microenvironment Remodeling for Enhanced Bladder Cancer Immunotherapy [ Research (Wash D C), 2025, 8:0735] PubMed: 40530387
Targeting HK3 in tumor-associated macrophages enhances antitumor immunity through augmenting antigen cross-presentation in cervical cancer [ J Immunother Cancer, 2025, 13(7)e011948] PubMed: 40664447
Arecoline upregulates CD155 expression to facilitate immune evasion in oral squamous cell carcinoma [ J Immunother Cancer, 2025, 13(12)e012982] PubMed: 41365532
USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment [ Cancer Immunol Res, 2025, 10.1158/2326-6066.CIR-24-1194] PubMed: 40323348
FAM135B Deficiency Inhibits Cytotoxic T-Cell Activity in Triple-negative Breast Cancer by Blocking the IFI16-dependent STING Pathway [ Cancer Immunol Res, 2025, 10.1158/2326-6066.CIR-25-0310] PubMed: 41218197

人間や獣医の診断であるか治療的な使用のためにでない。